TERRANOVA, CORRADO
 Distribuzione geografica
Continente #
AS - Asia 6.982
NA - Nord America 2.212
EU - Europa 924
SA - Sud America 346
AF - Africa 48
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.520
Nazione #
SG - Singapore 5.478
US - Stati Uniti d'America 2.090
CN - Cina 687
IT - Italia 456
HK - Hong Kong 399
BR - Brasile 252
VN - Vietnam 131
GB - Regno Unito 120
FR - Francia 111
BD - Bangladesh 93
DE - Germania 76
CA - Canada 62
IN - India 61
MX - Messico 42
AR - Argentina 41
NL - Olanda 27
CZ - Repubblica Ceca 18
JP - Giappone 18
TR - Turchia 17
IQ - Iraq 16
ZA - Sudafrica 16
ID - Indonesia 14
MD - Moldavia 13
RU - Federazione Russa 13
EC - Ecuador 12
FI - Finlandia 11
CL - Cile 10
EE - Estonia 9
PL - Polonia 9
CO - Colombia 8
ES - Italia 8
PH - Filippine 8
SA - Arabia Saudita 8
AT - Austria 7
PK - Pakistan 7
SE - Svezia 7
AU - Australia 6
EG - Egitto 6
MY - Malesia 6
UA - Ucraina 6
VE - Venezuela 6
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
TW - Taiwan 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KR - Corea 4
NP - Nepal 4
RS - Serbia 4
UZ - Uzbekistan 4
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CY - Cipro 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
LT - Lituania 2
MK - Macedonia 2
NG - Nigeria 2
PT - Portogallo 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CU - Cuba 1
ET - Etiopia 1
GN - Guinea 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LR - Liberia 1
ML - Mali 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RE - Reunion 1
RO - Romania 1
RW - Ruanda 1
Totale 10.515
Città #
San Jose 679
Singapore 518
Ashburn 504
Hong Kong 390
Rome 317
Hefei 212
Beijing 169
Boardman 117
Santa Clara 94
Lauterbourg 89
London 88
Shanghai 71
New York 48
Ho Chi Minh City 45
Los Angeles 40
San Francisco 35
Munich 33
Dallas 30
São Paulo 29
Buffalo 26
Montreal 24
Council Bluffs 23
Hanoi 22
Mexico City 22
Washington 22
Toronto 20
Brno 18
Amsterdam 16
Milan 15
Seattle 15
Tokyo 15
Rio de Janeiro 13
Secaucus 13
Naples 12
Brooklyn 11
Johannesburg 11
Pune 11
Chicago 10
Las Vegas 10
Da Nang 9
Grumo Nevano 9
Paris 9
Boston 8
Sorab 8
Warsaw 8
Coral Springs 6
Haiphong 6
Helsinki 6
Orem 6
Phoenix 6
Santiago 6
The Dalles 6
Baghdad 5
Catania 5
Duque de Caxias 5
Frankfurt am Main 5
Guangzhou 5
Guayaquil 5
Medellín 5
Stockholm 5
Temecula 5
Thái Bình 5
Ankara 4
Biên Hòa 4
Buenos Aires 4
Campinas 4
Canberra 4
Cape Town 4
Cuautitlán Izcalli 4
Dhaka 4
Guarulhos 4
Hyderabad 4
Kuala Lumpur 4
Lahore 4
New Delhi 4
Newark 4
Ninh Bình 4
Nuremberg 4
Ribeirão Preto 4
Riyadh 4
Salt Lake City 4
Taipei 4
Turku 4
Anápolis 3
Asunción 3
Bologna 3
Brasília 3
Caracas 3
Charlotte 3
Cleveland 3
Cusano Milanino 3
Dalian 3
Hải Dương 3
Karbala 3
Lima 3
Louisville 3
Manaus 3
Manchester 3
Montevideo 3
Mysore 3
Totale 4.115
Nome #
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 267
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 262
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 252
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 244
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 243
The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study 241
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies 239
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 232
Analysis of ultrasonographic and hystopathologic features of placental invasiveness in Vitro Fertilization (IVF) pregnancies: a prospective study 226
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 224
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 223
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 221
Human embryo: what about relatedness? 215
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study 214
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 209
Intraoperative contact ultrasonography during open myomectomy for uterine fibroids 207
Chronic subtorsion of the ovary with subsequent ovarian hypoplasia 206
Does HE4 have a role in the recurrence of ovarian cancer? 205
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 197
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 196
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 191
A critical review on HE4 performance in endometrial cancer: where are we now? 146
A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection 142
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 139
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 138
[The role of laparoscopy in ovarian carcinoma]. 134
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 123
A new type of absorbable barbed suture for use in laparoscopic myomectomy 122
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 121
Assessing HPV vaccination perceptions with online social media in Italy 117
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 117
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 116
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 115
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 113
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 112
Economic impact among family caregivers of patients with advanced ovarian cancer 111
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 110
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 107
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study 105
Chirurgia Benigna 105
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 102
The Rendezvous Technique: A Minimally Invasive Non-Surgical Approach for the Management of Iatrogenic Ureteral Injuries 96
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 84
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 82
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 80
The endogenous oxytocin after manipulative osteopathic treatment in full-term pregnant women 79
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 79
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 70
The role of ovarian fossa evaluation in patients with ovarian endometriosis 69
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 68
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 67
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 66
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 65
Miomectomia laparoscopica: fattibilità e learning curve 64
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 63
Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative Study 63
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers 58
Laparoscopic myomectomy learning curve safety and feasibility. 58
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 57
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. 57
Ovarian cancer relapse: From the latest scientific evidence to the best practice 56
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 56
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 56
PREOPERATIVE LOCAL STAGING OF ENDOMETRIAL CANCER: THE CHALLENGE OF IMAGING TECHNIQUES AND SERUM BIOMARKERS 55
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 55
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 55
Studio prospettico randomizzato comparativo tra due tecniche 54
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 54
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis 53
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test 52
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 52
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program 51
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix 49
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 48
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial 47
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature 46
Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature 46
Over-the-counter emergency contraception in Italy: ethical reflections and medico-legal issues 46
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 46
Ten years of HPV vaccines: State of art and controversies 46
Real-time infrared thermography for ureter detection during hysterectomy 46
Continuous wound infusion as a valid alternative to tap block for postoperative analgesia after abdominal hysterectomy: A randomized controlled trial 45
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 45
NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER 45
Dual HER2/PIK3CA targeting overcomes single-agent acquired resistance in HER2-amplified uterine serous carcinoma cell lines in vitro and in vivo 44
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 44
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 44
Hormone replacement therapy in cancer survivors: Utopia? 43
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 43
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 43
The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study 42
TOTAL RECTOSIGMOIDECTOMY VERSUS PARTIAL RECTAL RESECTION IN ADVANCED OVARIAN CANCER SURGICAL DEBULKING: A CASE CONTROL STUDY 42
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 41
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 41
Studio prospettico randomizzato comparativo tra due tecniche chirurgiche per il trattamento dell’incontinenza urinaria da sforzo: accesso retropubico vs transotturatorio 41
The role of macroplastique implantation in the management of occult urinary stress incontinence 41
RANDOMIZED CONTROL TRIAL COMPARING FOUR VERSUS SIX COURSES OF ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PREVIOUSLY TREATED WITH NEO-ADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY 41
Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature 40
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 40
ROBOTIC PELVIC LYMPHADENECTOMY: STEPS AND TECHNIQUE 40
Totale 10.308
Categoria #
all - tutte 54.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 3 1 0 0 1 4 4 3 0 122
2022/202351 0 0 1 2 1 1 12 2 3 3 17 9
2023/2024491 10 42 46 43 43 147 4 64 9 20 30 33
2024/20255.876 107 25 122 33 27 98 83 65 276 341 2.288 2.411
2025/20264.014 313 168 182 399 202 225 1.134 253 376 407 239 116
Totale 10.570